Rekover Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 2

Rekover Therapeutics General Information

Description

Manufacturer of therapeutics drug intended to target multiple sclerosis. The company offers drugs for the repair of tissue damage caused by multiple sclerosis, enabling customers to improve their health.

Contact Information

Website
www.rekovertherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care of Simon Wilkinson
  • 47 Bayliss Drive
  • Kaiapoi
  • New Zealand
Primary Industry
Pharmaceuticals
Corporate Office
  • Care of Simon Wilkinson
  • 47 Bayliss Drive
  • Kaiapoi
  • New Zealand

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rekover Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round Completed Clinical Trials - Phase 2
1. Seed Round 03-Feb-2021 Completed Clinical Trials - Phase 2
To view Rekover Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Rekover Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
KiwiNet Accelerator/Incubator Minority
Matu Venture Capital Minority
To view Rekover Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Rekover Therapeutics FAQs

  • When was Rekover Therapeutics founded?

    Rekover Therapeutics was founded in 2020.

  • Where is Rekover Therapeutics headquartered?

    Rekover Therapeutics is headquartered in Kaiapoi, New Zealand.

  • What industry is Rekover Therapeutics in?

    Rekover Therapeutics’s primary industry is Pharmaceuticals.

  • Is Rekover Therapeutics a private or public company?

    Rekover Therapeutics is a Private company.

  • What is Rekover Therapeutics’s current revenue?

    The current revenue for Rekover Therapeutics is .

  • Who are Rekover Therapeutics’s investors?

    KiwiNet and Matu have invested in Rekover Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »